ADENOID CYSTIC CARCINOMA
Clinical trials for ADENOID CYSTIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADENOID CYSTIC CARCINOMA trials appear
Sign up with your email to follow new studies for ADENOID CYSTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets rare Cancer's genetic driver
Disease control Recruiting nowThis early-stage study is testing a new oral medication called REM-422 for people with advanced adenoid cystic carcinoma (ACC), a rare cancer. The main goals are to find a safe and effective dose and to see if the drug can shrink or control tumors. The study will enroll about 100…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Remix Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New pill targets tough cancers after other treatments fail
Disease control Recruiting nowThis early-stage study is testing a new oral drug called VMD-928, both by itself and combined with an existing immunotherapy (pembrolizumab). It is for adults with advanced solid tumors or lymphoma that have progressed despite available treatments. The main goals are to find safe…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: VM Oncology, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Targeted radiation blasts early cancer spread in new trial
Disease control Recruiting nowThis study is testing whether using a highly focused type of radiation (SBRT) early on can help control cancer that has spread to a few sites. It will compare this approach to standard care in about 32 patients with adenoid cystic carcinoma. The main goals are to see if it delays…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Experimental drug targets multiple advanced cancers in first human test
Disease control Recruiting nowThis early-stage trial is testing a new cancer drug called NN3201 for the first time in people. The study aims to find a safe dose and see how well the drug works against several advanced solid tumors that have a specific protein called c-Kit. Researchers will enroll 67 adults wi…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE1 • Sponsor: Novelty Nobility, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Experimental drug trial offers hope for rare cancer patients
Disease control Recruiting nowThis study is testing whether the drug enfortumab vedotin can help control advanced adenoid cystic carcinoma, a rare cancer that has returned or spread. Researchers will enroll 34 adults whose cancer has progressed despite previous treatments. The trial will measure how well the …
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New pill targets tough cancers in First-Ever human trial
Disease control Recruiting nowThis is the first study in people to test a new oral medication called RGT-61159. It aims to see if the drug is safe and can help control tumors in adults with advanced adenoid cystic carcinoma or colorectal cancer that has returned or stopped responding to available treatments. …
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE1 • Sponsor: Rgenta Therapeutics Inc • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New weapon against tough cancers enters first human tests
Disease control Recruiting nowThis is the first study in people to test a new drug called XMT-1660 for several types of advanced solid tumors that have returned or spread. The main goals are to find a safe dose and see what side effects it causes. Researchers will also look for early signs that the drug can s…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE1 • Sponsor: Mersana Therapeutics • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Precision chemo blitz aims to spare patients major surgery in rare cancer fight
Disease control Recruiting nowThis study is testing a new, personalized treatment strategy for a rare and aggressive cancer in the nasal and sinus area. First, patients receive three sessions of chemotherapy delivered directly to the tumor to shrink it. Based on how well the tumor responds, doctors then tailo…
Matched conditions: ADENOID CYSTIC CARCINOMA
Phase: PHASE2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC